Abstract
In this issue of Blood, Brammer et al present a phase 1/2 trial that demonstrates in patients with T-large granular lymphocyte leukemia (T-LGLL) that ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
